Literature DB >> 21352199

Intracellular bacteria recognition contributes to maximal interleukin (IL)-12 production by IL-10-deficient macrophages.

H Naruse1, T Hisamatsu, Y Yamauchi, J E Chang, K Matsuoka, M T Kitazume, K Arai, S Ando, T Kanai, N Kamada, T Hibi.   

Abstract

Interleukin (IL)-12 is a key factor that induces T helper cell type 1-mediated immunity and inflammatory diseases. In some colitis models, such as IL-10 knock-out (KO) mice, IL-12 triggers intestinal inflammation. An abundant amount of IL-12 is produced by intestinal macrophages in response to stimulation by commensal bacteria in IL-10 KO mice. Intact bacteria are more potent inducers of macrophage IL-12 production than cell surface components in this model. This suggested that cell surface receptor signalling and intracellular pathogen recognition mechanisms are important for the induction of IL-12. We addressed the importance of intracellular recognition mechanisms and demonstrated that signal transducers and activator of transcription 1 (STAT1) signalling activated bacterial phagocytosis and was involved in the induction of abnormal IL-12 production. In IL-10 KO mouse bone marrow-derived (BM) macrophages, Escherichia coli stimulation induced increased IL-12p70 production compared to lipopolysaccharide combined with interferon (IFN)-γ treatment. Significant repression of IL-12 production was achieved by inhibition of phagocytosis with cytochalasin D, and inhibition of de novo protein synthesis with cycloheximide. Induction of IFN regulatory factors-1 and -8, downstream molecules of STAT1 and the key transcription factors for IK-12 transcription, following E. coli stimulation, were mediated by phagocytosis. Interestingly, STAT1 was activated after stimulation with E. coli in IL-10 KO BM macrophages, although IFN-γ could not be detected. These data suggest that molecules other than IFN-γ are involved in hyper-production mechanisms of IL-12 induced by E. coli stimulation. In conclusion, enteric bacteria stimulate excessive IL-12p70 production in IL-10 KO BM macrophages via phagocytosis-dependent signalling.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352199      PMCID: PMC3074226          DOI: 10.1111/j.1365-2249.2011.04318.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities.

Authors:  P D Smith; L E Smythies; M Mosteller-Barnum; D A Sibley; M W Russell; M Merger; M T Sellers; J M Orenstein; T Shimada; M F Graham; H Kubagawa
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

Review 2.  How microorganisms tip the balance between interleukin-12 family members.

Authors:  Stanislas Goriely; Markus F Neurath; Michel Goldman
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

3.  Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.

Authors:  F H Klebl; J E Olsen; S Jain; W F Doe
Journal:  J Pathol       Date:  2001-12       Impact factor: 7.996

4.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages.

Authors:  I M Wang; C Contursi; A Masumi; X Ma; G Trinchieri; K Ozato
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

6.  In vivo role of IFN-gamma produced by antigen-presenting cells in early host defense against intracellular pathogens.

Authors:  Kazutomo Suzue; Takashi Asai; Tsutomu Takeuchi; Shigeo Koyasu
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

7.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

8.  T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.

Authors:  K Matsuoka; N Inoue; T Sato; S Okamoto; T Hisamatsu; Y Kishi; A Sakuraba; O Hitotsumatsu; H Ogata; K Koganei; T Fukushima; T Kanai; M Watanabe; H Ishii; T Hibi
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

9.  Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1.

Authors:  Jianguo Liu; Shanjin Cao; Lisa M Herman; Xiaojing Ma
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

10.  Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.

Authors:  M G Cecchini; M G Dominguez; S Mocci; A Wetterwald; R Felix; H Fleisch; O Chisholm; W Hofstetter; J W Pollard; E R Stanley
Journal:  Development       Date:  1994-06       Impact factor: 6.868

View more
  2 in total

1.  Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine.

Authors:  Takanori Ochi; Yongjia Feng; Sho Kitamoto; Hiroko Nagao-Kitamoto; Peter Kuffa; Koji Atarashi; Kenya Honda; Daniel H Teitelbaum; Nobuhiko Kamada
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

2.  Wall teichoic acid-dependent phagocytosis of intact cell walls of Lactiplantibacillus plantarum elicits IL-12 secretion from macrophages.

Authors:  Naoya Kojima; Shohei Kojima; Shin Hosokawa; Yoshiki Oda; Daisuke Zenke; Yuta Toura; Emi Onohara; Shin-Ichi Yokota; Masato Nagaoka; Yasuhiro Kuroda
Journal:  Front Microbiol       Date:  2022-08-09       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.